Vertaling van "advertisement for medicines for human use intended " (Nederlands → Frans) :

Supervision of advertising ●● Every advertisement for medicines for human use intended for the general public is checked before publication.
Supervision of advertising ●● Every advertisement for medicines for human use intended for the general public is checked before publication.

Advisory commission which is consulted e.g. in cases of non-availability of medicines Commission for the approval of institutions assigning preliminary approvals for scientific events Commission for the establishment of retail pharmacies and chambers of appeal (Frenchspeaking chamber and Dutch-speaking chamber) Commission for the recognition of pharmacists-clinical biologists Commission for the supervision of advertising for medicines for human use Evaluation commission for active implantable medical devices Evaluation commission for homeopathic medicines Evaluation commission for medical devices Evaluation commission for medicines for human use Evaluation commission for medicines for veterinary use Evaluation commission for traditional herbal medicines Pharmacopoeia commission
Advisory commission which is consulted e.g. in cases of non-availability of medicines Commission for the approval of institutions assigning preliminary approvals for scientific events Commission for the establishment of retail pharmacies and chambers of appeal (Frenchspeaking chamber and Dutch-speaking chamber) Commission for the recognition of pharmacists-clinical biologists Commission for the supervision of advertising for medicines for human use Evaluation commission for active implantable medical devices Evaluation commission for homeopathic medicines Evaluation commission for medical devices Evaluation commission for medicines for human use Evaluation commission for medicines for veterinary use Evaluation commission for traditional herbal medicines Pharmacopoeia commission

In order to regulate the quality and relevance of messages to the public, a prior licence is required for radio and TV information campaigns about human health and illness which refer directly or indirectly to medicines. This licence is normally issued by the Minister responsible following advice from the Commission for the supervision of advertising for medicines for human use.
In order to regulate the quality and relevance of messages to the public, a prior licence is required for radio and TV information campaigns about human health and illness which refer directly or indirectly to medicines. This licence is normally issued by the Minister responsible following advice from the Commission for the supervision of advertising for medicines for human use.

checked prior to publication. Radio and television advertisements are provided with a licence after advice from the Commission for the supervision of advertising of medicines for human use or after notification to the FAMHP for the other media.
checked prior to publication. Radio and television advertisements are provided with a licence after advice from the Commission for the supervision of advertising of medicines for human use or after notification to the FAMHP for the other media.

The commission for the supervision of advertising of medicines for human use dealt with 61 approval applications for radio/TV advertising during 16 meetings
The commission for the supervision of advertising of medicines for human use dealt with 61 approval applications for radio/TV advertising during 16 meetings

Advisory commission that is consulted e.g. in cases of non-availability of medicines Commission for the approval of institutions assigning preliminary approvals for scientific events Commission for the establishment of retail pharmacies and chambers of appeal (French-speaking chamber and Dutch-speaking chamber) Commission for the recognition of pharmacistsclinical biologists Commission for the supervision of advertising for medicines for human use
Advisory commission that is consulted e.g. in cases of non-availability of medicines Commission for the approval of institutions assigning preliminary approvals for scientific events Commission for the establishment of retail pharmacies and chambers of appeal (French-speaking chamber and Dutch-speaking chamber) Commission for the recognition of pharmacistsclinical biologists Commission for the supervision of advertising for medicines for human use

The commission for the supervision of advertising of medicines for human use dealt with 7 approval applications for radio and television information campaigns
The commission for the supervision of advertising of medicines for human use dealt with 7 approval applications for radio and television information campaigns

De gegevens over de veiligheid van aliskiren werden recent herbekeken door het Committee for Medicinal Products for Human Use (CHMP) van het European Medicines Agency (EMA) [ www.ema.europa.eu/docs/en_GB/document_library/Medicine_QA/2012/02/WC500122916.pdf ].
Les données concernant le profil d’innocuité de l’aliskirène ont été récemment revues par le Committee for Medicinal Products for Human Use (CHMP) de l’Agence européenne des médicaments (EMA) [ www.ema.europa.eu/docs/en_GB/document_library/Medicine_QA/2012/02/ WC500122916.pdf ].

De " hulpstoffen met erkende werking" (met de toedieningsweg en de drempelwaarde vanaf dewelke effecten mogelijk zijn, en met uitleg over de risicogroepen) zijn gedefinieerd in het richtsnoer van de Europese Commissie " Excipients in the label and package leaflet of medicinal product for human use" (juli 2003, te raadplegen via [http ...]
Les " excipients à effet notoire " (avec la voie d’administration et la valeur-seuil à partir de laquelle des effets sont possibles, ainsi que des explications sur les groupes à risque) sont définis dans une directive de la Commission européenne " Excipients in the label and package leaflet of medicinal product for human use" (juillet 2003, à consulter sur [http ...]

- De “hulpstoffen met erkende werking” (met de toedieningsweg en de drempelwaarde vanaf dewelke effecten mogelijk zijn, en met uitleg over de risicogroepen) zijn gedefinieerd in het richtsnoer van de Europese Commissie “Excipients in the label and package leaflet of medicinal product for human use” (juli 2003, te raadplegen via [http ...]
- Les « excipients à effet notoire » (avec la voie d’administration et la valeur-seuil à partir de laquelle des effets sont possibles, ainsi que des explications sur les groupes à risque) sont définis dans une directive de la Commission européenne “Excipients in the label and package leaflet of medicinal product for human use” (juillet 2003, à consulter sur [http ...]